1. P323: STREAMLINING PRECLINICAL IN VIVO TREATMENT TRIALS BY MULTIPLEXING GENETICALLY LABELLED PDX MODELS OF SEVERAL PATIENTS IN A SINGLE MOUSE. (23rd June 2022) Authors: Hunt, K.; Amend, D.; Ludwig, R.; Vick, B.; Wirth, A. K.; Herold, T.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING. (23rd June 2022) Authors: Schmidt, C.; Janssen, M.; Bruch, P.-M.; Blank, M. F.; Rohde, C.; Waclawiczek, A.; Renders, S.; Heid, D.; Göllner, S.; Vierbaum, L.; Weidenauer, K.; Herbst, S.; Knoll, M.; Kolb, C.; Besenbeck, B.; Fabre, M.; Gu, M.; Schlenk, R.; Stölzel, F.; Bornhäuser, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S253: THE SHEDDASE DOMAIN OF ADAM10 AUGMENTS THE INTERACTION OF LEUKEMIA CELLS WITH THE BONE MARROW NICHE IN VIVO AS SHOWN BY RECONSTITUTING PDX LEUKEMIA CELLS WITH CRISPR-CAS9-INDUCED KNOCKOUT. (23rd June 2022) Authors: Schmid, J. P.; Bahrami, E.; Becker, M.; Jayavelu, A. K.; Wirth, A.-K.; Jurinovic, V.; Öllinger, R.; Rad, R; Vick, B.; Mann, M.; Herold, T.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗